CH Biotech R&D Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	394.13	478.86	939.93	530.02	321.01
Short-Term Investments	3.14	3.28	3.07	3.07	5.78
Cash & Short-Term Investments	397.27	482.13	943	533.1	326.79
Cash Growth	-17.60%	-48.87%	76.89%	63.13%	-0.93%
Accounts Receivable	246.02	162.83	106.07	33.3	161.14
Other Receivables	53.59	56.62	44.8	42.97	29.13
Receivables	299.61	219.45	150.87	76.27	190.27
Inventory	153.48	122.1	119.21	177.26	125.01
Prepaid Expenses	18.93	26.5	18.59	12.99	10.74
Other Current Assets	2.31	2.4	3.76	4.07	1.71
Total Current Assets	871.59	852.59	1,235	803.69	654.53
Property, Plant & Equipment	2,631	2,718	2,361	2,365	2,349
Long-Term Investments	26	29.1	29.36	-	-
Goodwill	2.45	2.45	2.45	2.45	2.45
Other Intangible Assets	8.75	3.43	3.71	5.82	5.39
Long-Term Deferred Tax Assets	6.79	2.84	3.21	2	2.23
Other Long-Term Assets	27.59	20.7	14.37	16.08	15.24
Total Assets	3,574	3,629	3,649	3,195	3,029
Accounts Payable	9.04	8.84	9.26	9.62	20.71
Accrued Expenses	0.19	0.23	0.35	0.41	0.19
Short-Term Debt	365	290	190	120	188
Current Portion of Long-Term Debt	107.28	107.28	385.6	120	140.76
Current Portion of Leases	25.56	24.33	28.18	21.62	16.83
Current Income Taxes Payable	66.8	54.11	119.28	76.02	68.35
Current Unearned Revenue	0.17	0.32	0.47	0.3	0.35
Other Current Liabilities	147.47	161.82	149.19	119.56	93.66
Total Current Liabilities	721.51	646.93	882.32	467.52	528.84
Long-Term Debt	31.98	189.26	-	385.6	523.18
Long-Term Leases	134.5	136.46	241.38	247.66	253.51
Pension & Post-Retirement Benefits	-	7.2	5.36	4.26	-
Long-Term Deferred Tax Liabilities	-	2.38	-	2.56	-
Other Long-Term Liabilities	0.48	0.21	-	-	-
Total Liabilities	888.48	982.44	1,129	1,108	1,306
Common Stock	1,028	1,028	1,028	970.83	844.2
Additional Paid-In Capital	718.53	718.26	717.64	331.32	331.32
Retained Earnings	930.12	877.19	771.2	782.37	570.21
Comprehensive Income & Other	9.35	22.42	3.3	3.16	-22.52
Total Common Equity	2,686	2,646	2,520	2,088	1,723
Minority Interest	-	0.87	-	-	-
Shareholders' Equity	2,686	2,647	2,520	2,088	1,723
Total Liabilities & Equity	3,574	3,629	3,649	3,195	3,029
Total Debt	664.33	747.33	845.16	894.89	1,122
Net Cash (Debt)	-267.05	-265.19	97.84	-361.79	-795.48
Net Cash Per Share	-2.59	-2.57	1.00	-3.67	-8.11
Filing Date Shares Outstanding	102.8	102.8	102.8	97.08	97.08
Total Common Shares Outstanding	102.8	102.8	102.8	97.08	97.08
Working Capital	150.08	205.66	353.1	336.16	125.69
Book Value Per Share	26.13	25.74	24.52	21.50	17.75
Tangible Book Value	2,675	2,640	2,514	2,079	1,715
Tangible Book Value Per Share	26.02	25.68	24.46	21.42	17.67
Land	502.39	546.51	143.24	143.26	109.81
Buildings	2,018	1,949	1,905	1,864	1,448
Machinery	892.56	823.54	576.15	476.33	358.65
Construction In Progress	35.68	40.12	60.5	73.28	508.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.